🇺🇸 FDA
Pipeline program

Chidamide Tablets; PD-L1 Inhibitor (as per chosen drug's prescribing information);Carboplatin; Etoposide

CSIIT-Q115

Phase 2 small_molecule active

Quick answer

Chidamide Tablets; PD-L1 Inhibitor (as per chosen drug's prescribing information);Carboplatin; Etoposide for Small Cell Lung Cancer is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Small Cell Lung Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials